• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过腹膜透析液给予庆大霉素:耳毒性风险

Gentamicin administration via peritoneal dialysis fluid: the risk of ototoxicity.

作者信息

Gendeh B S, Said H, Gibb A G, Aziz N S, Zahir Z M

机构信息

ENT Department, Faculty of Medicine, National University of Malaysia, Kuala Lumpur.

出版信息

J Laryngol Otol. 1991 Dec;105(12):999-1001. doi: 10.1017/s0022215100118055.

DOI:10.1017/s0022215100118055
PMID:1787382
Abstract

In a prospective study on 47 patients, 16 mg of gentamicin per two litres dialysate was administered intraperitoneally at every cycle of intermittent peritoneal dialysis, carried out over the course of several days. Serum gentamicin sampling, pure tone audiometry and caloric tests were performed before and during the treatment. The gentamicin levels reached at the end of the thirtieth cycle were observed to be low. In view of this, the risk of acute ototoxicity was considered to be minimal. This was confirmed by the absence of clinical audiometric or vestibulometric evidence of toxicity.

摘要

在一项针对47名患者的前瞻性研究中,在为期数天的间歇性腹膜透析的每个周期,每两升透析液腹腔内注射16毫克庆大霉素。在治疗前和治疗期间进行血清庆大霉素采样、纯音听力测定和冷热试验。观察到在第三十周期结束时庆大霉素水平较低。鉴于此,急性耳毒性风险被认为极小。临床听力测定或前庭功能测定未发现毒性证据,证实了这一点。

相似文献

1
Gentamicin administration via peritoneal dialysis fluid: the risk of ototoxicity.通过腹膜透析液给予庆大霉素:耳毒性风险
J Laryngol Otol. 1991 Dec;105(12):999-1001. doi: 10.1017/s0022215100118055.
2
Gentamicin ototoxicity in continuous ambulatory peritoneal dialysis.
J Laryngol Otol. 1993 Aug;107(8):681-5. doi: 10.1017/s0022215100124132.
3
Pharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study).腹腔内注射庆大霉素在腹膜炎患者腹膜透析中的药代动力学(GIPD 研究)。
Clin J Am Soc Nephrol. 2012 Aug;7(8):1249-56. doi: 10.2215/CJN.12211211. Epub 2012 Jun 14.
4
Ototoxicity monitoring with ultra-high frequency audiometry in peritoneal dialysis patients treated with vancomycin or gentamicin.使用超高频听力测定法对接受万古霉素或庆大霉素治疗的腹膜透析患者进行耳毒性监测。
ORL J Otorhinolaryngol Relat Spec. 1991;53(1):19-22. doi: 10.1159/000276178.
5
Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.在接受持续性非卧床腹膜透析和持续性循环腹膜透析的终末期肾病患者中,使用大剂量腹腔内氨基糖苷类药物治疗腹膜炎。
Adv Perit Dial. 2000;16:280-4.
6
Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study.优化腹膜炎患者腹腔内庆大霉素剂量(GIPD)研究。
BMC Nephrol. 2009 Dec 16;10:42. doi: 10.1186/1471-2369-10-42.
7
The use of gentamicin in peritoneal dialysis. I. Pharmacologic results.
J Infect Dis. 1971 Dec;124 Suppl:S77-83. doi: 10.1093/infdis/124.supplement_1.s77.
8
Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes.英国单中心关于腹膜透析相关性腹膜炎治疗的经验——抗生素水平与治疗结果
Nephrol Dial Transplant. 2007 Jun;22(6):1714-9. doi: 10.1093/ndt/gfm079. Epub 2007 Mar 17.
9
The use of gentamicin in peritoneal dialysis. II. Microbiologic and clinical results.庆大霉素在腹膜透析中的应用。II. 微生物学及临床结果。
J Infect Dis. 1971 Dec;124 Suppl:S84-9. doi: 10.1093/infdis/124.supplement_1.s84.
10
Acute massive gentamicin intoxication in a patient with end-stage renal disease.
Am J Kidney Dis. 1996 Nov;28(5):767-71. doi: 10.1016/s0272-6386(96)90263-2.

引用本文的文献

1
ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.国际腹膜透析学会腹膜炎推荐意见:2016年预防与治疗更新版
Perit Dial Int. 2016 Sep 10;36(5):481-508. doi: 10.3747/pdi.2016.00078. Epub 2016 Jun 9.
2
Drug-induced tinnitus and other hearing disorders.药物性耳鸣及其他听力障碍。
Drug Saf. 1996 Mar;14(3):198-212. doi: 10.2165/00002018-199614030-00006.